Last updated: 25 September 2023 at 5:36pm EST

Daniel Omstead Net Worth




The estimated Net Worth of Daniel R Omstead is at least $4.29 Million dollars as of 25 September 2023. Mr. Omstead owns over 10,096 units of abrdn Healthcare Opportunities Fund stock worth over $4,292,066 and over the last 20 years he sold THQ stock worth over $0. In addition, he makes $0 as President and Trustee at abrdn Healthcare Opportunities Fund.

Mr. Omstead THQ stock SEC Form 4 insiders trading

Daniel has made over 45 trades of the abrdn Healthcare Opportunities Fund stock since 2004, according to the Form 4 filled with the SEC. Most recently he bought 10,096 units of THQ stock worth $125,089 on 25 September 2023.

The largest trade he's ever made was buying 12,000 units of abrdn Healthcare Opportunities Fund stock on 20 September 2023 worth over $152,160. On average, Daniel trades about 4,658 units every 146 days since 2004. As of 25 September 2023 he still owns at least 197,518 units of abrdn Healthcare Opportunities Fund stock.

You can see the complete history of Mr. Omstead stock trades at the bottom of the page.





Daniel Omstead biography

Daniel R. Omstead Ph.D. serves as President, Trustee of the Company., He is President and Chief Executive Officer of Tekla Capital Management LLC (the "Adviser"), a registered investment adviser that serves as investment adviser to the Funds. Dr. Omstead is also President of the Funds and serves on their Valuation Committee. Dr. Omstead is portfolio manager for the public and restricted/venture portfolios within the Funds. As part of these responsibilities, Dr. Omstead is a member of the Board of Directors of a portfolio company, IlluminOss Medical, Inc. Prior to joining the Adviser, Dr. Omstead was President and CEO of Reprogenesis, Inc., a private development stage biotech company which developed therapies in the field of tissue engineering and regenerative medicine. Before joining Reprogenesis, Dr. Omstead was Senior Vice President, Research and Development, at Cytotherapeutics, Inc, a public biotech company. Prior to entering the biotech industry, Dr. Omstead was employed for fourteen years in positions of increasing responsibility within the pharmaceutical industry at Ortho Pharmaceutical Corporation and at the R.W. Johnson Pharmaceutical Research Institute, both divisions of Johnson & Johnson, and at Merck, Sharp and Dohme Research Laboratories, a division of Merck & Co., Inc. Dr. Omstead provides each Fund with insights into both pharmaceutical and biotech companies. Dr. Omstead holds Ph.D. and Master's Degrees in Chemical Engineering and Applied Chemistry from Columbia University and a B.S. degree in Civil Engineering from Lehigh University. He is an emeritus member of the Board of Directors of a non-profit agency that provides emergency shelter, housing and supportive services to homeless and low-income individuals and families in the Boston area. Dr. Omstead was also a member of the Board of Trustees at the Joslin Diabetes Center.



How old is Daniel Omstead?

Daniel Omstead is 67, he's been the President and Trustee of abrdn Healthcare Opportunities Fund since 2014. There are 5 older and 1 younger executives at abrdn Healthcare Opportunities Fund. The oldest executive at abrdn Healthcare Opportunities Fund is William Reardon, 74, who is the Independent Trustees.

What's Daniel Omstead's mailing address?

Daniel's mailing address filed with the SEC is C/O TEKLA HEALTHCARE INVESTORS, 100 FEDERAL STREET, 19TH FLOOR, BOSTON, MA, 02110.

Insiders trading at abrdn Healthcare Opportunities Fund

Over the last 10 years, insiders at abrdn Healthcare Opportunities Fund have traded over $0 worth of abrdn Healthcare Opportunities Fund stock and bought 44,516 units worth $798,865 . The most active insiders traders include Daniel R Omstead, Jeffrey Allen Bailey, and Michael W Bonney. On average, abrdn Healthcare Opportunities Fund executives and independent directors trade stock every 214 days with the average trade being worth of $56,911. The most recent stock trade was executed by Rose Di Martino on 16 July 2024, trading 1,000 units of THQ stock currently worth $21,300.



What does abrdn Healthcare Opportunities Fund do?

tekla life sciences investors is a closed-ended equity mutual fund launched and managed by tekla capital management llc. the fund invests in public equity markets across the globe. it seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical equipment, hospitals, healthcare information technology and services, devices and supplies industries, and in agriculture and environmental management industries. the fund primarily invests in growth stocks of small cap companies. it employs fundamental analysis with a focus on factors such as market position for services or products, experience of business management, technological expertise, and the ability either to generate funds internally to finance growth or to secure outside sources of capital to create its portfolio. the fund benchmarks the performance of its portfolio against the nasdaq biotech index and the s&p 500 index. it was form



What does abrdn Healthcare Opportunities Fund's logo look like?

abrdn Healthcare Opportunities Fund logo

Complete history of Mr. Omstead stock trades at abrdn Healthcare Investors, abrdn Life Sciences Investors, abrdn Healthcare Opportunities Fund, and abrdn World Healthcare Fund

Date
#
Company
Insider
Trans.
Transaction
Shares Price per share Total value Shares after Source
25 Sep 2023 Daniel R Omstead
President
Buy 10,096 $12.39 $125,089
25 Sep 2023
197,518
20 Sep 2023 Daniel R Omstead
President
Buy 12,000 $12.68 $152,160
20 Sep 2023
187,422
11 Aug 2021 Daniel R Omstead
President
Buy 6,403 $21.63 $138,497
11 Aug 2021
146,489
26 Oct 2020 Daniel R Omstead
President
Buy 6,175 $17.52 $108,186
26 Oct 2020
131,835
21 Oct 2020 Daniel R Omstead
President
Buy 5,950 $17.75 $105,613
21 Oct 2020
125,660
21 May 2020 Daniel R Omstead
President
Buy 5,950 $17.74 $105,553
21 May 2020
114,820
17 Mar 2020 Daniel R Omstead
President
Buy 8,300 $13.27 $110,141
17 Mar 2020
105,813
4 Jun 2013 Daniel R Omstead
President
Buy 6,000 $17.58 $105,480
4 Jun 2013
40,980
8 Aug 2011 Daniel R Omstead
President
Buy 10,000 $10.03 $100,300
8 Aug 2011
29,360
6 Aug 2009 Daniel R Omstead
President
Buy 3,000 $8.61 $25,830
6 Aug 2009
17,622
26 Nov 2008 Daniel R Omstead
President
Buy 2,000 $6.89 $13,780
26 Nov 2008
13,518
10 Oct 2008 Daniel R Omstead
President
Buy 2,000 $7.90 $15,800
10 Oct 2008
11,518
21 Nov 2007 Daniel R Omstead
President
Buy 1,500 $12.50 $18,750
21 Nov 2007
8,674
3 Aug 2007 Daniel R Omstead
President
Buy 1,000 $13.20 $13,200
3 Aug 2007
7,021
28 Sep 2006 Daniel R Omstead
President
Buy 1,666 $12.82 $21,358
28 Sep 2006
5,665
1 Apr 2005 Daniel R Omstead
President
Buy 2,900 $14.50 $42,050
1 Apr 2005
3,965
29 Jul 2004 Daniel R Omstead
President
Buy 400 $14.38 $5,752
29 Jul 2004
1,020
25 Sep 2023 Daniel R Omstead
President
Buy 9,500 $15.63 $148,485
25 Sep 2023
178,268
20 Sep 2023 Daniel R Omstead
President
Buy 9,500 $15.88 $150,860
20 Sep 2023
168,768
26 Oct 2020 Daniel R Omstead
President
Buy 5,200 $20.53 $106,756
26 Oct 2020
125,411
21 Oct 2020 Daniel R Omstead
President
Buy 5,050 $20.68 $104,434
21 Oct 2020
120,211
21 May 2020 Daniel R Omstead
President
Buy 5,000 $21.01 $105,050
21 May 2020
110,357
17 Mar 2020 Daniel R Omstead
President
Buy 6,800 $16.24 $110,432
17 Mar 2020
102,318
26 Dec 2018 Daniel R Omstead
President
Buy 6,300 $17.14 $107,982
26 Dec 2018
85,406
25 Oct 2018 Daniel R Omstead
President
Buy 5,500 $20.43 $112,365
25 Oct 2018
79,106
17 Oct 2018 Daniel R Omstead
President
Buy 3,882 $21.78 $84,550
17 Oct 2018
73,606
4 Jun 2013 Daniel R Omstead
President
Buy 5,000 $21.45 $107,250
4 Jun 2013
33,326
8 Aug 2011 Daniel R Omstead
President
Buy 8,100 $12.37 $100,197
8 Aug 2011
24,491
6 Aug 2009 Daniel R Omstead
President
Buy 3,000 $10.70 $32,100
6 Aug 2009
14,908
26 Nov 2008 Daniel R Omstead
President
Buy 2,000 $8.97 $17,940
26 Nov 2008
11,034
10 Oct 2008 Daniel R Omstead
President
Buy 387 $11.40 $4,412
10 Oct 2008
9,034
21 Nov 2007 Daniel R Omstead
President
Buy 1,500 $15.82 $23,730
21 Nov 2007
7,902
3 Oct 2007 Daniel R Omstead
President
Buy 1,500 $17.40 $26,100
3 Oct 2007
6,402
3 Aug 2007 Daniel R Omstead
President
Buy 1,000 $16.79 $16,790
3 Aug 2007
4,799
1 Apr 2005 Daniel R Omstead
President
Buy 2,700 $16.30 $44,010
1 Apr 2005
3,535
29 Jul 2004 Daniel R Omstead
President
Buy 800 $16.76 $13,408
29 Jul 2004
800
17 Mar 2020 Daniel R Omstead
President
Buy 9,926 $10.77 $106,903
17 Mar 2020
24,326
26 Dec 2018 Daniel R Omstead
President
Buy 9,400 $11.11 $104,434
26 Dec 2018
14,400
25 Jun 2015 Daniel R Omstead
President
Buy 5,000 $20.00 $100,000
25 Jun 2015
5,000
17 Mar 2020 Daniel R Omstead
President
Buy 7,300 $14.67 $107,091
17 Mar 2020
31,202
25 Oct 2018 Daniel R Omstead
President
Buy 6,000 $17.43 $104,580
25 Oct 2018
23,902
17 Oct 2018 Daniel R Omstead
President
Buy 5,902 $18.19 $107,357
17 Oct 2018
17,902
11 Oct 2018 Daniel R Omstead
President
Buy 5,500 $17.59 $96,745
11 Oct 2018
12,000
10 Oct 2018 Daniel R Omstead
President
Buy 5,500 $18.27 $100,485
10 Oct 2018
6,500
28 Jul 2014 Daniel R Omstead
President
Buy 1,000 $20.00 $20,000
28 Jul 2014
1,000


abrdn Healthcare Opportunities Fund executives and stock owners

abrdn Healthcare Opportunities Fund executives and other stock owners filed with the SEC include: